Related Experiment Video
Updated: Jun 2, 2026

Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods
Published on: March 10, 2020
Molecular and developmental mechanisms of congenital heart valve disease
Joy Lincoln1, Katherine E Yutzey
1Department of Molecular and Cellular Pharmacology, Leonard M. Miller School of Medicine, University of Miami, 1400 Northwest 10th Avenue, Miami, FL, USA.
Insights
Congenital heart valve disease, including bicuspid aortic valve (BAV) and mitral valve prolapse (MVP), affects more individuals than previously thought. Understanding molecular pathways is key to developing new treatments beyond valve replacement.
Area of Science:
- Cardiovascular Biology
- Developmental Biology
- Genetics
Background:
- Congenital heart disease affects ~1% of live births, often involving heart valve abnormalities.
- Conditions like bicuspid aortic valve (BAV) and mitral valve prolapse (MVP) manifest later, leading to progressive valve dysfunction.
- Current treatment relies on valve replacement, with ~95,000 surgeries annually in the US.
Purpose of the Study:
- To review the molecular regulatory pathways controlling heart valve development.
- To explore how these pathways contribute to congenital valve disease.
- To discuss the therapeutic implications of this understanding.
Main Methods:
- Review of current literature on heart valve development and disease.
- Analysis of findings from murine and avian model systems.
- Inclusion of human genetic linkage studies.
Main Results:
- Identified genes and regulatory processes implicated in valve structural malformations.
- Highlighted abnormal valve cusp morphogenesis (e.g., BAV) and extracellular matrix (ECM) defects (e.g., MVP) as key issues.
- Emphasized the largely unknown etiology of common congenital valve diseases.
Conclusions:
- Molecular regulatory pathways are crucial in heart valve development and disease.
- Further research into these pathways offers potential for novel therapeutic strategies.
- Understanding genetic and regulatory factors is essential for addressing congenital valve disease.
Abstract:
Congenital heart disease occurs in approximately 1% of all live births and includes structural abnormalities of the heart valves. However, this statistic underestimates congenital valve lesions, such as bicuspic aortic valve (BAV) and mitral valve prolapse (MVP), that typically become apparent later in life as progressive valve dysfunction and disease. At present, the standard treatment for valve disease is replacement, and approximately 95,000 surgical procedures are performed each year in the United States. The most common forms of congenital valve disease include abnormal valve cusp morphogenesis, as in the case of BAV, or defects in extracellular matrix (ECM) organization and homeostasis, as occurs in MVP. The etiology of these common valve diseases is largely unknown. However, the study of murine and avian model systems, along with human genetic linkage studies, have led to the identification of genes and regulatory processes that contribute to valve structural malformations and disease. This review focuses on the current understanding and therapeutic implications of molecular regulatory pathways that control valve development and contribute to valve disease.
Related Concept Videos
Mitral Valve Prolapse I: Introduction
Heart Valves
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
Mitral Stenosis I: Introduction
Development of the Heart
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Mitral Regurgitation I: Introduction

